The eight key areas biopharma manufacturers must stay on top of when planning and executing alliance agreements with prospective digital health partners.
Emily Lowe, Michele Buenafe, and Kelli Boyle
Advertisement
Emily Lowe, Michele Buenafe, and Kelli Boyle — Morgan, Lewis & Bockius LLP.
Articles by Emily Lowe, Michele Buenafe, and Kelli Boyle
Advertisement
Latest Updated Articles
Digital-Deal Alignment: Considerations for Tech AgreementsPublished: May 13th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
3
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
4
Could DTC Programs Help Simplify the Drug-Pricing System?
5
